2015 - 2018 Molecular mechanism underling improvement of oxaliplatin-induced neuropathy by duloxetine
2015 - 2017 Different etiologic mechanisms underlying HFS depending on the classes of anti-cancer agents
2014 - 2016 Roles of anti-inflammatory system after drug-induced kidney injury
2012 - 2015 Individualized L-dopa therapy in patients with Parkinson's disease
Show all
Papers (101):
Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Shinya Yamamoto, Takeshi Matsubara, Sho Masui, Shunsaku Nakagawa, Yasuaki Ikemi, Motoko Yanagita, Manabu Muto, et al. Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer chemotherapy and pharmacology. 2024
Tomoya Kawakami, Sho Masui, Akira Onishi, Hideo Onizawa, Takayuki Fujii, Kosaku Murakami, Koichi Murata, Masao Tanaka, Takashi Shimada, Shunsaku Nakagawa, et al. Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort. Modern rheumatology. 2024
Keisuke Umemura, Yoshiki Katada, Shunsaku Nakagawa, Daiki Hira, Yojiro Yutaka, Satona Tanaka, Akihiro Ohsumi, Daisuke Nakajima, Hiroshi Date, Miki Nagao, et al. Comparison of the safety and cost-effectiveness of nebulized liposomal amphotericin B and amphotericin B deoxycholate for antifungal prophylaxis after lung transplantation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024